Masayasu Takahashi Selected Research

YM 872

3/2003	The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats.
1/2002	YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayasu Takahashi Research Topics

Disease

3	Femoral Neck Fractures 02/2020 - 09/2015
3	Pain (Aches) 12/2017 - 01/2012
3	Neoplasm Metastasis (Metastasis) 05/2006 - 10/2003
2	Fibromyalgia (Fibrositis) 12/2017 - 01/2012
2	Myalgia 12/2017 - 01/2012
2	Neuralgia (Stump Neuralgia) 02/2016 - 01/2012
2	Necrosis 11/2013 - 09/2011
2	Infarction (Infarctions) 01/2008 - 01/2002
2	Stroke (Strokes) 01/2008 - 01/2002
1	Hip Fractures (Intertrochanteric Fractures) 01/2017
1	Hyperalgesia 02/2016
1	False Aneurysm (Pseudoaneurysm) 12/2013
1	Avulsion Fractures 11/2013
1	Contracture 01/2013
1	Femoral Fractures (Femoral Fracture) 01/2013
1	Chronic Pain 01/2012
1	Rheumatoid Arthritis 02/2010
1	Osteoarthritis 02/2010
1	Sigmoid Neoplasms 05/2006
1	Vomiting 05/2006
1	Nausea 05/2006
1	Diarrhea 05/2006
1	Lymphatic Metastasis 09/2005
1	Stomach Neoplasms (Stomach Cancer) 09/2005
1	Hemorrhage 08/2005
1	Carcinoma (Carcinomatosis) 08/2005
1	Neoplasms (Cancer) 08/2005
1	Cholecystolithiasis 01/2004
1	Wounds and Injuries (Trauma) 01/2004
1	Colorectal Neoplasms (Colorectal Cancer) 10/2003
1	Craniocerebral Trauma (Head Injury) 03/2003
1	Brain Injuries (Brain Injury) 03/2003
1	Brain Edema (Cerebral Edema) 03/2003
1	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2003
1	Ischemic Stroke 01/2002
1	Ischemia 01/2002

Drug/Important Bio-Agent (IBA)

3	Neuroprotective AgentsIBA 01/2008 - 01/2002
3	Leucovorin (Folinic Acid)FDA Link 05/2006 - 10/2003
2	ElementsIBA 05/2018 - 09/2015
2	Reserpine (Serpasil)FDA Link 12/2017 - 01/2012
2	Pharmaceutical PreparationsIBA 02/2016 - 01/2002
2	Fluorouracil (Carac)FDA LinkGeneric 08/2005 - 10/2003
2	AMPA Receptors (AMPA Receptor)IBA 03/2003 - 01/2002
2	YM 872IBA 03/2003 - 01/2002
1	Butylated Hydroxyanisole (BHA)IBA 02/2020
1	Analgesics (Analgesic Drugs)IBA 12/2017
1	Pregabalin (Lyrica)FDA Link 02/2016
1	MetalsIBA 11/2013
1	Mexiletine (Mexitil)FDA LinkGeneric 01/2012
1	Biogenic Amines (Biogenic Amine)IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 09/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2008
1	N- cyclohexyl- 6- (((2- methoxyethyl)(methyl)amino)methyl)- N- methylthiazolo(3,2- a)benzimidazole- 2- carboxamideIBA 01/2008
1	titanium silicide (TS-1)IBA 09/2005
1	Dacarbazine (DIC)FDA LinkGeneric 01/2004
1	salicylhydroxamic acid (SHAM)IBA 03/2003
1	Glutamic Acid (Glutamate)FDA Link 03/2003

Therapy/Procedure

2	External Fixators 11/2013 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2012 - 10/2003
1	Arthroplasty 02/2020
1	Hip Prosthesis 01/2017
1	Hemiarthroplasty 01/2017
1	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2013
1	Therapeutics 05/2006
1	Gastrectomy 09/2005
1	Pancreaticoduodenectomy 08/2005
1	Cholecystectomy 01/2004
1	Intravenous Infusions 01/2004